AL amyloidosis therapeutics (BELLUS Health)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug NameAL amyloidosis therapeutics (BELLUS Health)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsImmunoglobulin Light-chain Amyloidosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBellus Health Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBellus Health Inc

Active IndicationsN/A

Inactive IndicationsImmunoglobulin Light-chain Amyloidosis

ATC CodeN/A